Related references
Note: Only part of the references are listed.High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?
Priyanka A. Pophali et al.
BLOOD CANCER JOURNAL (2020)
Patients with double/triple copy number gains on C-MYC, BCL2, and/or BCL6 treated with standard chemotherapy have a similarly poor prognosis than those with high-grade B cell lymphoma with C-MYC and BCL2 and/or BCL6 rearrangements: a single-center experience on a consecutive cohort of large B cell lymphomas
Ella Willenbacher et al.
ANNALS OF HEMATOLOGY (2020)
Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma
Sixia Huang et al.
DIAGNOSTIC PATHOLOGY (2019)
Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium
Andreas Rosenwald et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Correlation Between C-MYC, BCL-2, and BCL-6 Protein Expression and Gene Translocation as Biomarkers in Diagnosis and Prognosis of Diffuse Large B-cell Lymphoma
YunXiang Zhang et al.
FRONTIERS IN PHARMACOLOGY (2019)
High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology
David W. Scott et al.
BLOOD (2018)
Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements
Pierre Sesques et al.
BLOOD (2017)
Prognostic impact of MYC protein expression in central nervous system diffuse large B-cell lymphoma: comparison with MYC rearrangement and MYC mRNA expression
Seung-Myoung Son et al.
MODERN PATHOLOGY (2017)
Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma
Andres E. Quesada et al.
MODERN PATHOLOGY (2017)
Further Exploration of the Complexities of Large B-Cell Lymphomas With MYC Abnormalities and the Importance of a Blastoid Morphology
Erika M. Moore et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis
Shaoying Li et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Definition of MYC genetic heteroclonality in diffuse large B-cell lymphoma with 8q24 rearrangement and its impact on protein expression
Alexandra Valera et al.
MODERN PATHOLOGY (2016)
MYC and metabolism on the path to cancer
Annie L. Hsieh et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
The prognosis of MYC translocation positive diffuse large B-cell lymphoma depends on the second hit
Alexandra Clipson et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2015)
Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
Alexandar Tzankov et al.
MODERN PATHOLOGY (2014)
Double-hit B-cell Lymphomas With BCL6 and MYC Translocations Are Aggressive, Frequently Extranodal Lymphomas Distinct From BCL2 Double-hit B-cell Lymphomas
Raju K. Pillai et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
Heike Horn et al.
BLOOD (2013)
B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases
Anamarija M. Perry et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
Alexandra Valera et al.
HAEMATOLOGICA (2013)
Double-hit BCL2/MYC translocations in a consecutive cohort of patients with large B-cell lymphoma - a single centre's experience
Mette O. Pedersen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
High-grade B cell lymphoma, unclassifiable, with blastoid features: an unusual morphological subgroup associated frequently with BCL2 and/or MYC gene rearrangements and a poor prognosis
Rashmi Kanagal-Shamanna et al.
HISTOPATHOLOGY (2012)
Does the proliferation fraction help identify mature B cell lymphomas with double- and triple-hit translocations?
Emarene Mationg-Kalaw et al.
HISTOPATHOLOGY (2012)
Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP
Monica Testoni et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
B-cell Lymphomas With Concurrent IGH-BCL2 and MYC Rearrangements Are Aggressive Neoplasms With Clinical and Pathologic Features Distinct From Burkitt Lymphoma and Diffuse Large B-cell Lymphoma
Matija Snuderl et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma
Christopher J. Stasik et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Rearrangement of MYC Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab
Sharon Barrans et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
Nathalie A. Johnson et al.
BLOOD (2009)
Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations
Naoto Tomita et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Adult B-cell lymphomas with Burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior
RE McClure et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
CP Hans et al.
BLOOD (2004)
Translocations involving c-myc and c-myc function
LM Boxer et al.
ONCOGENE (2001)
Chromosomal analyses of 52 cases of follicular lymphoma with t(14;18), including blastic/blastoid variant
AN Mohamed et al.
CANCER GENETICS AND CYTOGENETICS (2001)
Share Paper
